About Curepharma
Curepharma is a private limited company (BV/SRL) based in Antwerpen, founded in 1983. Its main activity is classified as "Detailhandel in farmaceutische producten". For the 2025 financial year, Curepharma reported a loss of €63,131. A year earlier, in 2024, it still made a profit of €4,763. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €46,344, down 46% on 2024. It employed an average of 1.2 full-time equivalents. Equity stands at €355,161, a solvency ratio of 69%. In 2006 it was €44,775. 20 annual accounts are available, covering 2006 to 2025.
- Sectors
- Pharmacies
- Signals
-
Reporting lossesReporting losses € -63K
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -48KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -45KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 355KStrong equity provides a buffer against setbacks.
Low riskLow risk 68.8%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.74A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Healthy social debtHealthy social debt 10.9%Social debts stay manageable relative to personnel costs.
- Shareholders
- Saravi 100%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
46K
|
€
86K
|
€
114K
|
€
193K
|
|
|
€
-45K
|
€
11K
|
€
39K
|
€
103K
|
|
|
€
-63K
|
€
5K
|
€
23K
|
€
77K
|
|
|
€
355K
|
€
418K
|
€
414K
|
€
460K
|
|
|
68.82%
|
77.47%
|
75.27%
|
76.92%
|
|
|
€
161K
|
€
122K
|
€
136K
|
€
138K
|
|
|
€
166K
|
€
243K
|
€
276K
|
€
367K
|
|
|
1.20
|
0.60
|
1
|
1
|
Publications 29
All publications- Wijziging Rechtsvorm - Benaming 03/01/2024
- Ontslagen - Benoemingen 25/10/2022
- Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 09/10/2018
- Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 09/07/2018
- Me. - Jaarrekening 31.12.2015, Ggk 27.05.2016, Ngl 23.06.2016 16217-0055-014 28/06/2016
Frequently asked questions
Answers to the most common questions about Curepharma, based on official government data and the filed annual accounts.
What is the VAT number of Curepharma?
The VAT number of Curepharma is BE0425.132.687.
How many employees work at Curepharma?
In 2025, Curepharma employed 1.20 full-time equivalents (FTE).
When was Curepharma established?
Curepharma was founded in 29-12-1983.
What is the official address of Curepharma?
The official address of Curepharma is Camille Huysmanslaan 95 Antwerpen 2020.
What is the legal form of Curepharma?
The juridical form of Curepharma is Private limited company (BV/SRL).
What is the annual revenue of Curepharma?
The 2025 accounts of Curepharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Curepharma a reliable company?
Curepharma is a registered Rechtspersoon with company number 0425.132.687 and can be verified through the official CBE database.
What is the credit limit of Curepharma?
The estimated credit limit of Curepharma is €17,314.
Is Curepharma still active?
Curepharma currently has the status "Normal situation" and is active.